Merck Drops $3.85B On Hep C Drug Co. Idenix
Pharmaceutical giant Merck & Co. Inc. is set to buy Idenix Pharmaceuticals Inc. for about $3.85 billion, the companies said Monday, putting Merck in control of a biopharmaceutical company featuring a...To view the full article, register now.
Already a subscriber? Click here to view full article